Article
Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia.
EBioMedicine - 1 Dec 2020
Wada Yuina, Maekawa Motoko, Ohnishi Tetsuo, Balan Shabeesh, Matsuoka Shigeru, Iwamoto Kazuya, Iwayama Yoshimi, Ohba Hisako, Watanabe Akiko, Hisano Yasuko, Nozaki Yayoi, Toyota Tomoko, Shimogori Tomomi, Itokawa Masanari, Kobayashi Tetsuyuki, Yoshikawa Takeo
Abstract excerpt
BACKGROUND: The pathophysiology of schizophrenia, a major psychiatric disorder, remains elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor (RXR) families, belonging to the ligand-activated nuclear receptor superfamily, in schizophrenia, was analyzed. METHODS: The PPAR/RXR family genes were screened by exploiting molecular inversion probe (MIP)-based targeted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
